Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO 2018 | Improved subtype characterization of endometrial cancer

Carien Creutzberg • 18 Jan 2019
ESMO 2018
Endometrial Cancer Gynecological Cancer

The Cancer Genome Atlas (TCGA) has recently characterized four distinct molecular subgroups of endometrial cancer phenotypes. Carien Creutzberg, MD, PhD, of the Leiden University Medical Center, Leiden, Netherlands explains the implications and the latest PORTEC trial (NCT03469674) that aims to further define these subgroups in clinically meaningful ways. This interview was recorded at the European Society for Medical Oncology (ESMO) 2018 Congress, in Munich, Germany.

More from Carien Creutzberg

1:34
Defining risk profiles of endometrial cancer
Carien Creutzberg • 18 Jan 2019
1:10
Matching treatment to molecular profiles in endometrial cancer
Carien Creutzberg • 18 Jan 2019
0:55
Making endometrial cancer more receptive to treatment
Carien Creutzberg • 18 Jan 2019
0:56
Exciting prospects for endometrial cancer treatment
Carien Creutzberg • 18 Jan 2019

Related Videos

0:39
Early diagnosis of ovarian cancer with Pap smears
Sergio Marchini • 8 Apr 2024
0:46
FRa expression and sequencing ADCs in endometrial cancer
Rebecca Porter • 8 Apr 2024
4:12
PETRA: saruparib in solid tumors with BRCA1/2, PALB2 or RAD51C/D mutations
Timothy Yap • 7 Apr 2024
1:11
Clonal hematopoiesis mutations in ovarian carcinomas
Rebecca Porter • 8 Apr 2024
The content of VJOncology is intended for healthcare professionals